The headquarters of Anglo-Swedish pharmaceutical company AstraZeneca in Macclesfield, England, November 20, 2008. AstraZeneca said on Monday that it had agreed to buy US firm Pearl Therapeutics for up to $1.15 billion (871 million euros).
The headquarters of Anglo-Swedish pharmaceutical company AstraZeneca in Macclesfield, England, November 20, 2008
